[1]马丽.冠心病二级预防用药出院带药情况分析[J].西部中医药,2013,26(07):58-60.
 MA Li.Analysis on Prescribed Medications for Discharged Patients in Secondary Prevention of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(07):58-60.
点击复制

冠心病二级预防用药出院带药情况分析
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年07期
页码:
58-60
栏目:
出版日期:
2013-07-15

文章信息/Info

Title:
Analysis on Prescribed Medications for Discharged Patients in Secondary Prevention of Coronary Heart Disease
文章编号:
1004-6852(2013)07-0058-03
作者:
马丽
张掖医学高等专科学校,甘肃 张掖 734000
Author(s):
MA Li
Zhangye Medical College, Zhangye 734000, China
关键词:
冠心病二级预防出院带药调查分析
Keywords:
coronary heart disease (CHD) secondary prevention prescribed medications when discharged investigation
分类号:
R541.4
文献标志码:
A
摘要:
目的:通过调查冠心病(CHD)患者出院带药情况,了解CHD二级预防药物的使用情况。方法:对张掖市人民医院近3年296例CHD患者出院带药情况(主要为二级预防药物)进行回顾性分析。结果:296例CHD患者中266例有出院带药记录。出院带药情况为:抗血小板药(97.7%)、他汀类药物(87.7%)、β受体阻断剂(71.4%)、血管紧张素转换酶抑制剂(ACEI)/血管紧张素受体拮抗剂(ARB)(64.3%),平均带药种类为(3.25±0.8)种。结论:从CHD二级预防药物出院带药率情况来看,该院医生对CHD二级预防非常重视,但存在指导用药不规范的问题,抗血小板药、他汀类药物带药率高,β受体阻断剂、ACEI/ARB带药率较低。
Abstract:
Objective: To know the conditions of secondary prevention medicine through surveying the prescribed medications for discharged patients with coronary heart disease(CHD). Method: The prescribed medications (mainly secondary prevention medicine) for 296 patients discharged from people's hospital of Zhangye in recent three years were retrospectively analyzed. Result: There were 266 patients with the records of prescribed medications when discharged among 296 patients. The conditions were: antiplatelet drugs (97.7%), statins (87.7%), β receptor blocker(71.4%), ACEI/ARB(64.3%), average types of drugs (3.25±0.80). Conclusion: Doctors emphasize secondary prevention of CHD from the conditions of prescribed medications when CHD patients were discharged, but the prescribed medications are confused and need to be improved, antiplatelet drugs and statins are prescribed more when CHD patients were discharged, while β receptor blocker and ACEI/ARB are prescribed less.

相似文献/References:

[1]马思清 指导:谢春毅.瓜蒌薤白三方防治冠心病的研究现状[J].西部中医药,2012,25(10):118.
 MA Si-qing Director: XIE Chun-yi.Exploration on Three Pieces of GuaLou XieBaiFang in the Prevention of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(07):118.
[2]潘雪晖.综合护理干预对冠心病患者不良生活方式的影响[J].西部中医药,2013,26(07):105.
 PAN Xuehui.Impact of Comprehensive Nursing Intervention on Lifestyles of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(07):105.
[3]袁春玲.家庭病床冠心病护理可行性探讨[J].西部中医药,2012,25(07):109.
 YUAN Chun-ling.Probe into Feasibility of Nursing for Patients with Coronary Heart Disease in Family Practice[J].Western Journal of Traditional Chinese Medicine,2012,25(07):109.
[4]王凯,林文.丹红与丹参酮ⅡA治疗冠心病心绞痛疗效比较[J].西部中医药,2013,26(08):88.
 WANG Kai,LIN Wen.Comparison between DanHong Injection and Tanshinone ⅡA in Treating Angina Pectoris of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(07):88.
[5]赵云霞,刘正跃.综合护理干预对冠心病患者不良生活方式的影响[J].西部中医药,2012,25(05):105.
 ZHAO Yun-xia,LIU Zheng-yue.Effects of Comprehensive Nursing Intervention on Unhealthy Lifestyle of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(07):105.
[6]王瑞福.调脂汤对冠心病PCI术后血液流变学及血脂的影响[J].西部中医药,2013,26(12):71.
 WANG Ruifu.Effects of TiaoZhi Tang on Blood Lipid and Rheology of the Patients with Coronary Heart Disease After PCI[J].Western Journal of Traditional Chinese Medicine,2013,26(07):71.
[7]孙文,谢春毅△.丹红注射液治疗冠心病心绞痛临床观察[J].西部中医药,2014,27(03):5.
 SUN Wen,XIE Chunyi.Clinical Observation on DanHong Injection in Treating Coronary Heart Disease Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2014,27(07):5.
[8]付伟光,齐振勇,李爱军,等.HCY、HS-CRP、LP(a)及 D- 二聚体联合检测在冠心病病程中动态检测意义的研究*[J].西部中医药,2014,27(08):148.
[9]张丽君,赵江花,赵海红,等.心脉疏膏穴位贴敷结合西药治疗冠心病心绞痛 40 例[J].西部中医药,2014,27(09):128.
[10]张红丽,刘海荣△,王媛,等.综合护理对老年冠心病心绞痛患者生活质量的影响[J].西部中医药,2014,27(10):143.

备注/Memo

备注/Memo:
收稿日期:2012-12-11 作者简介:马丽(1968—),女,副教授。研究方向:心血管疾病的诊断与治疗。
更新日期/Last Update: 2013-07-15